Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Drug Price Revisions Drive Divide in Q1 Health Care Results for Chemical, Material Firms

Filed Under: Industry, Pharma Tagged With: , , , , , , , , , ,

Revisions made to Japan’s national drug pricing in April have driven a wedge between the health care business results of…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Chemical and Material Companies Hit Crossroad on Health Care Strategy
Chemical and Material Companies Hit Crossroad on Health Care…
Large Japanese Chemical and Material Firms to Generate Earnings from Health Care
Large Japanese Chemical and Material Firms to Generate…
Japan’s Chemical and Material Giants Look Set to Post Run of Record-High Profits for Health Care-Related Segments
Japan’s Chemical and Material Giants Look Set to Post Run of…
Fujifilm, JSR Stand out Among Major Chemical–Material Manufacturers in Health Care-Related Operations for First Half
Fujifilm, JSR Stand out Among Major Chemical–Material…
Five of Japan's Eight Chemical Giants Post Record Profits for April–December Period
Five of Japan's Eight Chemical Giants Post Record Profits…
Major Chemical and Raw Material Companies Post Higher Than Expected Results From Health Care Operations
Major Chemical and Raw Material Companies Post Higher Than…